HEPION PHARMACEUTICALS, INC. Current Assets
HEPION PHARMACEUTICALS, INC. (HEPA) had Current Assets of $1.93 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $1.93M.
- 2026-03-31: Assets, Current $2.71M.
- 2025-12-31: Assets, Current $3.07M.
- 2025-09-30: Assets, Current $3.74M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $1.93M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.71M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.07M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.74M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.51M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $6.32M 10-Q · filed 2025-05-19 |
| 2024-12-31 | $1.61M 10-K · filed 2026-03-12 |
| 2024-09-30 | $3.53M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $5.48M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $15.43M 10-Q · filed 2024-05-21 |
| 2023-12-31 | $17.49M 10-K · filed 2025-04-08 |
| 2023-09-30 | $21.27M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $32.76M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $45.81M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $56.50M 10-K · filed 2024-04-16 |
| 2022-09-30 | $65.67M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $79.53M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $89.77M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $97.45M 10-K · filed 2023-04-10 |
| 2021-09-30 | $105.50M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $113.67M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $117.74M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $42.63M 10-K · filed 2022-04-08 |
| 2020-09-30 | $14.35M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $18.17M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $17.31M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $14.39M 10-K · filed 2021-03-31 |
| 2019-09-30 | $15.18M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $17.39M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.91M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.97M 10-K · filed 2020-05-14 |
| 2018-09-30 | $9.16M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.74M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $4.15M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $6.06M 10-K · filed 2019-03-14 |
| 2017-09-30 | $8.94M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $13.19M 10-KT · filed 2018-03-26 |
| 2017-03-31 | $6.56M 10-Q · filed 2017-04-12 |
| 2016-12-31 | $10.86M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $3.61M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $7.89M 10-KT · filed 2018-03-26 |
| 2016-03-31 | $6.63M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $10.52M 10-Q · filed 2016-02-12 |
| 2015-09-30 | $2.72M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.24M 10-K · filed 2016-09-28 |
| 2015-03-31 | $9.36M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $8.85M 10-Q · filed 2015-02-12 |
| 2014-09-30 | $893.45K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.98M 10-K · filed 2015-09-25 |
| 2014-03-31 | $2.63M 10-Q · filed 2014-05-15 |
| 2013-06-30 | $86.72K 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |